Evidence map›Paper›PMID 33498621›Full record

ArticleMolecules (Basel, Switzerland)2021

The Alkaloid-Enriched Fraction of

Dagmar Flittner, Marcel Kaiser, Pascal Mäser, Norberto P Lopes, Thomas J Schmidt

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Antiprotozoal Aminosteroids fromMolecules (Basel, Switzerland) · 2025
    Article
  4. Identification of Antiprotozoal Compounds fromMolecules (Basel, Switzerland) · 2021
    Article
  5. AntiprotozoalAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dagmar FlittnerInstitute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus, Corrensstr. 48, D-48149 Münster, Germany.
Marcel KaiserSwiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, CH-4051 Basel, Switzerland.
Pascal MäserSwiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, CH-4051 Basel, Switzerland.ORCID 0000-0003-3122-1941
Norberto P LopesNúcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS), Department of Biomolecular Sciences from School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. Do Café s/n CEP, 14040-903 Ribeirão Preto-SP, Brazil.ORCID 0000-0002-8159-3658
Thomas J SchmidtInstitute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus, Corrensstr. 48, D-48149 Münster, Germany.ORCID 0000-0003-2634-9705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the course of our studies on antiprotozoal natural products and following our recent discovery that certain aminosteroids and aminocycloartanoid compounds from

Indexed as

AlkaloidsAntiprotozoal AgentsApocynaceaeBuxaceaeBuxusHolarrhenaPachysandraPlant ExtractsTrypanocidal AgentsTrypanosoma brucei rhodesienseAlkaloidsAntiprotozoal AgentsPlant ExtractsTrypanocidal AgentsBuxaceaemass spectrometryPachysandra terminalissteroid alkaloidTrypanosoma brucei

Identifiers

PMID33498621
PMCPMC7865568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.